Subtopic Deep Dive
Onychomycosis Epidemiology
Research Guide
What is Onychomycosis Epidemiology?
Onychomycosis epidemiology studies the prevalence, incidence, risk factors, and global distribution of fungal nail infections primarily caused by dermatophytes.
Prevalence reaches about 10% in the U.S. population (Elewski, 1998, 573 citations). Multicenter surveys report 6.5-8% prevalence in Canadian physicians' offices (Gupta et al., 2000, 381 citations) and higher rates in diabetics (Gupta et al., 1998, 337 citations). UK omnibus surveys found 3-6.8% dermatophyte onychomycosis in adults (Roberts, 1992, 337 citations). Over 50 papers detail these patterns since 1990.
Why It Matters
Epidemiological data guide public health resource allocation for onychomycosis, affecting millions with rising prevalence in Western countries (Thomas et al., 2010, 309 citations). Diabetic patients face 2-3 times higher toenail onychomycosis rates, complicating foot care and increasing secondary infection risks (Gupta et al., 1998, 337 citations). Regional surveys inform targeted antifungal distribution and screening programs (Gupta et al., 2000, 381 citations; Roberts, 1992, 337 citations). Understanding age, obesity, and comorbidity trends supports cost-effective management strategies (Gupta et al., 2017, 259 citations).
Key Research Challenges
Heterogeneous Prevalence Estimates
Surveys vary by population and methods, with U.S. rates at 10% (Elewski, 1998) versus UK 3-6.8% (Roberts, 1992). Diagnostic criteria differences hinder meta-analysis. Standardized protocols are needed for global comparisons.
Risk Factor Quantification
Diabetes elevates rates but exact odds ratios differ across studies (Gupta et al., 1998). Age, obesity, and smoking interactions lack consistent modeling. Prospective cohort data remains sparse.
Regional Variation Analysis
Western increases noted but tropical data gaps persist (Thomas et al., 2010). Climate and ethnicity effects understudied. Multicenter global surveys are required.
Essential Papers
Onychomycosis: Pathogenesis, Diagnosis, and Management
Boni E. Elewski · 1998 · Clinical Microbiology Reviews · 573 citations
SUMMARY Although not life-threatening, onychomycosis (a fungal infection of the nail, usually caused by a dermatophyte) constitutes an important public health problem because of its high prevalence...
Prevalence and epidemiology of onychomycosis in patients visiting physicians’ offices: A multicenter Canadian survey of 15,000 patients
Aditya K. Gupta, Hem C. Jain, Charles Lynde et al. · 2000 · Journal of the American Academy of Dermatology · 381 citations
Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicentre survey
Aditya K. Gupta, Konnikov, MacDonald et al. · 1998 · British Journal of Dermatology · 337 citations
The number of individuals diagnosed with diabetes mellitus is increasing. The diabetic may present with complications involving all systems of the body. While onychomycosis is often observed in dia...
Prevalence of dermatophyte onychomycosis in the United Kingdom: Results of an omnibus survey
David T. Roberts · 1992 · British Journal of Dermatology · 337 citations
A computer omnibus survey to determine the prevalence of onychomycosis in the United Kingdom was carried out in the early part of 1990. A total population of 9332 adults, aged 16 years and over, wa...
Malassezia ecology, pathophysiology, and treatment
Bart Theelen, Claudia Cafarchia, Georgios Gaitanis et al. · 2017 · Medical Mycology · 320 citations
Malassezia are lipid dependent basidiomycetous yeasts that inhabit the skin and mucosa of humans and other warm-blooded animals, and are a major component of the skin microbiome. They occur as skin...
REVIEW ARTICLE: Toenail onychomycosis: an important global disease burden
Jackson Thomas, Glenn A. Jacobson, Christian Narkowicz et al. · 2010 · Journal of Clinical Pharmacy and Therapeutics · 309 citations
Onychomycosis is a fungal infection of the nail plate or nail bed. It does not usually cure itself and it can trigger more infectious lesions in other parts of the body. The reported prevalence of ...
Deep neural networks show an equivalent and often superior performance to dermatologists in onychomycosis diagnosis: Automatic construction of onychomycosis datasets by region-based convolutional deep neural network
Seung Seog Han, Gyeong‐Hun Park, Woohyung Lim et al. · 2018 · PLoS ONE · 285 citations
Although there have been reports of the successful diagnosis of skin disorders using deep learning, unrealistically large clinical image datasets are required for artificial intelligence (AI) train...
Reading Guide
Foundational Papers
Start with Elewski (1998, 573 citations) for U.S. prevalence baseline, then Gupta et al. (2000, 381 citations) for large-scale survey methods, and Roberts (1992, 337 citations) for population sampling.
Recent Advances
Study Gupta et al. (2017, 259 citations) for 21st-century updates on risk factors and Thomas et al. (2010, 309 citations) for global burden trends.
Core Methods
Core techniques include omnibus surveys (Roberts, 1992), multicenter clinical assessments (Gupta et al., 2000), and prevalence meta-analysis in diabetics (Gupta et al., 1998).
How PapersFlow Helps You Research Onychomycosis Epidemiology
Discover & Search
Research Agent uses searchPapers and exaSearch to find prevalence surveys like Gupta et al. (2000, 381 citations), then citationGraph reveals clusters around Elewski (1998). findSimilarPapers expands to diabetic-focused works like Gupta et al. (1998).
Analyze & Verify
Analysis Agent applies readPaperContent to extract prevalence rates from Gupta et al. (2000), then runPythonAnalysis with pandas computes meta-analytic pooled estimates across surveys. verifyResponse (CoVe) and GRADE grading assess evidence quality for diabetic risk factors from Gupta et al. (1998).
Synthesize & Write
Synthesis Agent detects gaps in regional data via contradiction flagging between Roberts (1992) and Thomas et al. (2010), while Writing Agent uses latexEditText, latexSyncCitations for Elewski (1998), and latexCompile to generate epidemiology review manuscripts with exportMermaid for prevalence trend diagrams.
Use Cases
"Run meta-analysis on onychomycosis prevalence in diabetics from provided papers."
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas meta-analysis on Gupta 1998, Elewski 1998) → GRADE grading → CSV export of pooled ORs and CIs.
"Draft LaTeX review on global onychomycosis epidemiology citing top 5 papers."
Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations (Gupta 2000, Roberts 1992) → latexCompile → PDF with embedded citation graph.
"Find code for onychomycosis image datasets from Han et al. 2018."
Research Agent → paperExtractUrls (Han 2018) → Code Discovery → paperFindGithubRepo → githubRepoInspect → Python sandbox verification of dataset loaders.
Automated Workflows
Deep Research workflow conducts systematic review: searchPapers on 'onychomycosis prevalence' → citationGraph → readPaperContent on top 20 → GRADE + runPythonAnalysis for pooled prevalence. DeepScan applies 7-step verification to diabetic risk claims from Gupta et al. (1998), outputting checkpoint-validated report. Theorizer generates hypotheses on rising prevalence trends from Thomas et al. (2010) and Elewski (1998).
Frequently Asked Questions
What is onychomycosis epidemiology?
It examines prevalence (e.g., 10% U.S., Elewski 1998), incidence, risk factors like diabetes (Gupta et al., 1998), and distribution patterns via surveys (Gupta et al., 2000; Roberts, 1992).
What methods determine prevalence?
Multicenter physician office surveys (Gupta et al., 2000, n=15,000), omnibus population interviews (Roberts, 1992, n=9,332), and diabetic clinic assessments (Gupta et al., 1998) use clinical exams and mycology.
What are key papers?
Elewski (1998, 573 citations) on U.S. burden; Gupta et al. (2000, 381 citations) on Canada; Gupta et al. (1998, 337 citations) on diabetics; Roberts (1992, 337 citations) on UK.
What open problems exist?
Global standardization of diagnostics, prospective incidence studies, and modeling of comorbidities like obesity (Gupta et al., 2017) remain unresolved.
Research Nail Diseases and Treatments with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Onychomycosis Epidemiology with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Nail Diseases and Treatments Research Guide